Global AI-based Diabetic Eye Disease Screening System Market Growth (Status and Outlook) 2026-2032
The global AI-based Diabetic Eye Disease Screening System market size is predicted to grow from US$ 374 million in 2025 to US$ 599 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.
AI-based diabetic eye disease screening systems are intelligent diagnostic support tools developed using deep learning, computer vision, and medical image analysis technologies. These systems capture retinal images—using fundus cameras, ultra-widefield fundus cameras, or portable retinal cameras—and employ AI algorithms, such as convolutional neural networks, to automatically detect diabetic retinopathy, diabetic macular edema (DME), and other fundus abnormalities. Based on international clinical grading standards, they generate outputs regarding the need for referral, the severity of lesions, and preliminary diagnostic findings. Typically integrating features such as image quality assessment, automated lesion detection, disease grading, risk prediction, electronic medical record (EMR) interfaces, and cloud-based data management, these systems can be deployed in hospitals, primary care facilities, health check-up centers, diabetes clinics, and mobile medical settings. This enables large-scale, efficient, and standardized screening for diabetic eye disease, thereby increasing early detection rates and alleviating the shortage of ophthalmologists.
As the global diabetic population grows and diabetic retinopathy emerges as a leading cause of adult blindness—coupled with strengthened government policies on screening for diabetes complications—the market for AI-based diabetic eye disease screening systems is entering a phase of rapid commercialization. In recent years, countries and regions including the United States, China, Europe, Japan, and India have approved AI-assisted fundus screening products for clinical use, marking the transition of AI from a research concept to a standardized medical tool. Looking ahead, driven by improvements in AI algorithm accuracy, the widespread adoption of non-mydriatic fundus cameras, the digitalization of primary care, and the refinement of health insurance reimbursement systems, AI screening systems will expand from tertiary hospitals to community clinics, health check-up centers, pharmacies, mobile screening units, and home health management settings. Furthermore, by integrating cloud computing, telemedicine, large-model-assisted diagnostics, multi-disease screening, and continuous health management services, these systems will form a comprehensive business model—"Device + AI Software + Cloud Platform + Chronic Disease Management"—with the global market expected to maintain high growth rates in the coming years.
United States market for AI-based Diabetic Eye Disease Screening System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for AI-based Diabetic Eye Disease Screening System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for AI-based Diabetic Eye Disease Screening System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key AI-based Diabetic Eye Disease Screening System players cover Eyenuk, AEYE Health, Optomed, Remidio, Retmarker, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “AI-based Diabetic Eye Disease Screening System Industry Forecast” looks at past sales and reviews total world AI-based Diabetic Eye Disease Screening System sales in 2025, providing a comprehensive analysis by region and market sector of projected AI-based Diabetic Eye Disease Screening System sales for 2026 through 2032. With AI-based Diabetic Eye Disease Screening System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-based Diabetic Eye Disease Screening System industry.
This Insight Report provides a comprehensive analysis of the global AI-based Diabetic Eye Disease Screening System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI-based Diabetic Eye Disease Screening System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-based Diabetic Eye Disease Screening System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-based Diabetic Eye Disease Screening System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-based Diabetic Eye Disease Screening System.
This report presents a comprehensive overview, market shares, and growth opportunities of AI-based Diabetic Eye Disease Screening System market by product type, application, key players and key regions and countries.
AI-based diabetic eye disease screening systems are intelligent diagnostic support tools developed using deep learning, computer vision, and medical image analysis technologies. These systems capture retinal images—using fundus cameras, ultra-widefield fundus cameras, or portable retinal cameras—and employ AI algorithms, such as convolutional neural networks, to automatically detect diabetic retinopathy, diabetic macular edema (DME), and other fundus abnormalities. Based on international clinical grading standards, they generate outputs regarding the need for referral, the severity of lesions, and preliminary diagnostic findings. Typically integrating features such as image quality assessment, automated lesion detection, disease grading, risk prediction, electronic medical record (EMR) interfaces, and cloud-based data management, these systems can be deployed in hospitals, primary care facilities, health check-up centers, diabetes clinics, and mobile medical settings. This enables large-scale, efficient, and standardized screening for diabetic eye disease, thereby increasing early detection rates and alleviating the shortage of ophthalmologists.
As the global diabetic population grows and diabetic retinopathy emerges as a leading cause of adult blindness—coupled with strengthened government policies on screening for diabetes complications—the market for AI-based diabetic eye disease screening systems is entering a phase of rapid commercialization. In recent years, countries and regions including the United States, China, Europe, Japan, and India have approved AI-assisted fundus screening products for clinical use, marking the transition of AI from a research concept to a standardized medical tool. Looking ahead, driven by improvements in AI algorithm accuracy, the widespread adoption of non-mydriatic fundus cameras, the digitalization of primary care, and the refinement of health insurance reimbursement systems, AI screening systems will expand from tertiary hospitals to community clinics, health check-up centers, pharmacies, mobile screening units, and home health management settings. Furthermore, by integrating cloud computing, telemedicine, large-model-assisted diagnostics, multi-disease screening, and continuous health management services, these systems will form a comprehensive business model—"Device + AI Software + Cloud Platform + Chronic Disease Management"—with the global market expected to maintain high growth rates in the coming years.
United States market for AI-based Diabetic Eye Disease Screening System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for AI-based Diabetic Eye Disease Screening System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for AI-based Diabetic Eye Disease Screening System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key AI-based Diabetic Eye Disease Screening System players cover Eyenuk, AEYE Health, Optomed, Remidio, Retmarker, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “AI-based Diabetic Eye Disease Screening System Industry Forecast” looks at past sales and reviews total world AI-based Diabetic Eye Disease Screening System sales in 2025, providing a comprehensive analysis by region and market sector of projected AI-based Diabetic Eye Disease Screening System sales for 2026 through 2032. With AI-based Diabetic Eye Disease Screening System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-based Diabetic Eye Disease Screening System industry.
This Insight Report provides a comprehensive analysis of the global AI-based Diabetic Eye Disease Screening System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI-based Diabetic Eye Disease Screening System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-based Diabetic Eye Disease Screening System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-based Diabetic Eye Disease Screening System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-based Diabetic Eye Disease Screening System.
This report presents a comprehensive overview, market shares, and growth opportunities of AI-based Diabetic Eye Disease Screening System market by product type, application, key players and key regions and countries.
Segmentation by Type:
- On-premise
- Cloud-based
- Hybrid Mode
Segmentation by Business Model:
- Software Licensing
- SaaS Subscription
- Per-Screening Fee
- Integrated AI + Hardware Sales
- Others
Segmentation by Application:
- General Hospitals
- Ophthalmology Hospitals
- Diabetes Specialty Hospitals
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eyenuk
- AEYE Health
- Optomed
- Remidio
- Retmarker
- VoxelCloud
- Airdoc
- Zhiyuan Huitu
- IDx, LLC
- Zhenhealth
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
2.1.2 AI-based Diabetic Eye Disease Screening System Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for AI-based Diabetic Eye Disease Screening System by Country/Region (2021, 2025 & 2032)
2.2 AI-based Diabetic Eye Disease Screening System Segment by Type
2.2.1 On-premise
2.2.2 Cloud-based
2.2.3 Hybrid Mode
2.2.4 AI-based Diabetic Eye Disease Screening System Market Size by Type
2.2.4.1 AI-based Diabetic Eye Disease Screening System Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
2.3 AI-based Diabetic Eye Disease Screening System Segment by Business Model
2.3.1 Software Licensing
2.3.2 SaaS Subscription
2.3.3 Per-Screening Fee
2.3.4 Integrated AI + Hardware Sales
2.3.5 Others
2.3.6 AI-based Diabetic Eye Disease Screening System Market Size by Business Model
2.3.6.1 AI-based Diabetic Eye Disease Screening System Market Size CAGR by Business Model (2021 VS 2025 VS 2032)
2.3.6.2 Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model (2021-2026)
2.4 AI-based Diabetic Eye Disease Screening System Segment by Application
2.4.1 General Hospitals
2.4.2 Ophthalmology Hospitals
2.4.3 Diabetes Specialty Hospitals
2.4.4 AI-based Diabetic Eye Disease Screening System Market Size by Application
2.4.4.1 AI-based Diabetic Eye Disease Screening System Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.4.4.2 Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
3 AI-BASED DIABETIC EYE DISEASE SCREENING SYSTEM MARKET SIZE BY PLAYER
3.1 AI-based Diabetic Eye Disease Screening System Market Size Market Share by Player
3.1.1 Global AI-based Diabetic Eye Disease Screening System Revenue by Player (2021-2026)
3.1.2 Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Player (2021-2026)
3.2 Global AI-based Diabetic Eye Disease Screening System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-BASED DIABETIC EYE DISEASE SCREENING SYSTEM BY REGION
4.1 AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026)
4.2 Global AI-based Diabetic Eye Disease Screening System Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI-based Diabetic Eye Disease Screening System Market Size Growth (2021-2026)
4.4 APAC AI-based Diabetic Eye Disease Screening System Market Size Growth (2021-2026)
4.5 Europe AI-based Diabetic Eye Disease Screening System Market Size Growth (2021-2026)
4.6 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
5.2 Americas AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
5.3 Americas AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026)
6.2 APAC AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
6.3 APAC AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
7.2 Europe AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
7.3 Europe AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI-based Diabetic Eye Disease Screening System by Region (2021-2026)
8.2 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
8.3 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI-BASED DIABETIC EYE DISEASE SCREENING SYSTEM MARKET FORECAST
10.1 Global AI-based Diabetic Eye Disease Screening System Forecast by Region (2027-2032)
10.1.1 Global AI-based Diabetic Eye Disease Screening System Forecast by Region (2027-2032)
10.1.2 Americas AI-based Diabetic Eye Disease Screening System Forecast
10.1.3 APAC AI-based Diabetic Eye Disease Screening System Forecast
10.1.4 Europe AI-based Diabetic Eye Disease Screening System Forecast
10.1.5 Middle East & Africa AI-based Diabetic Eye Disease Screening System Forecast
10.2 Americas AI-based Diabetic Eye Disease Screening System Forecast by Country (2027-2032)
10.2.1 United States Market AI-based Diabetic Eye Disease Screening System Forecast
10.2.2 Canada Market AI-based Diabetic Eye Disease Screening System Forecast
10.2.3 Mexico Market AI-based Diabetic Eye Disease Screening System Forecast
10.2.4 Brazil Market AI-based Diabetic Eye Disease Screening System Forecast
10.3 APAC AI-based Diabetic Eye Disease Screening System Forecast by Region (2027-2032)
10.3.1 China AI-based Diabetic Eye Disease Screening System Market Forecast
10.3.2 Japan Market AI-based Diabetic Eye Disease Screening System Forecast
10.3.3 Korea Market AI-based Diabetic Eye Disease Screening System Forecast
10.3.4 Southeast Asia Market AI-based Diabetic Eye Disease Screening System Forecast
10.3.5 India Market AI-based Diabetic Eye Disease Screening System Forecast
10.3.6 Australia Market AI-based Diabetic Eye Disease Screening System Forecast
10.4 Europe AI-based Diabetic Eye Disease Screening System Forecast by Country (2027-2032)
10.4.1 Germany Market AI-based Diabetic Eye Disease Screening System Forecast
10.4.2 France Market AI-based Diabetic Eye Disease Screening System Forecast
10.4.3 UK Market AI-based Diabetic Eye Disease Screening System Forecast
10.4.4 Italy Market AI-based Diabetic Eye Disease Screening System Forecast
10.4.5 Russia Market AI-based Diabetic Eye Disease Screening System Forecast
10.5 Middle East & Africa AI-based Diabetic Eye Disease Screening System Forecast by Region (2027-2032)
10.5.1 Egypt Market AI-based Diabetic Eye Disease Screening System Forecast
10.5.2 South Africa Market AI-based Diabetic Eye Disease Screening System Forecast
10.5.3 Israel Market AI-based Diabetic Eye Disease Screening System Forecast
10.5.4 Turkey Market AI-based Diabetic Eye Disease Screening System Forecast
10.6 Global AI-based Diabetic Eye Disease Screening System Forecast by Type (2027-2032)
10.7 Global AI-based Diabetic Eye Disease Screening System Forecast by Application (2027-2032)
10.7.1 GCC Countries Market AI-based Diabetic Eye Disease Screening System Forecast
11 KEY PLAYERS ANALYSIS
11.1 Eyenuk
11.1.1 Eyenuk Company Information
11.1.2 Eyenuk AI-based Diabetic Eye Disease Screening System Product Offered
11.1.3 Eyenuk AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Eyenuk Main Business Overview
11.1.5 Eyenuk Latest Developments
11.2 AEYE Health
11.2.1 AEYE Health Company Information
11.2.2 AEYE Health AI-based Diabetic Eye Disease Screening System Product Offered
11.2.3 AEYE Health AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 AEYE Health Main Business Overview
11.2.5 AEYE Health Latest Developments
11.3 Optomed
11.3.1 Optomed Company Information
11.3.2 Optomed AI-based Diabetic Eye Disease Screening System Product Offered
11.3.3 Optomed AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Optomed Main Business Overview
11.3.5 Optomed Latest Developments
11.4 Remidio
11.4.1 Remidio Company Information
11.4.2 Remidio AI-based Diabetic Eye Disease Screening System Product Offered
11.4.3 Remidio AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Remidio Main Business Overview
11.4.5 Remidio Latest Developments
11.5 Retmarker
11.5.1 Retmarker Company Information
11.5.2 Retmarker AI-based Diabetic Eye Disease Screening System Product Offered
11.5.3 Retmarker AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Retmarker Main Business Overview
11.5.5 Retmarker Latest Developments
11.6 VoxelCloud
11.6.1 VoxelCloud Company Information
11.6.2 VoxelCloud AI-based Diabetic Eye Disease Screening System Product Offered
11.6.3 VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 VoxelCloud Main Business Overview
11.6.5 VoxelCloud Latest Developments
11.7 Airdoc
11.7.1 Airdoc Company Information
11.7.2 Airdoc AI-based Diabetic Eye Disease Screening System Product Offered
11.7.3 Airdoc AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Airdoc Main Business Overview
11.7.5 Airdoc Latest Developments
11.8 Zhiyuan Huitu
11.8.1 Zhiyuan Huitu Company Information
11.8.2 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product Offered
11.8.3 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Zhiyuan Huitu Main Business Overview
11.8.5 Zhiyuan Huitu Latest Developments
11.9 IDx, LLC
11.9.1 IDx, LLC Company Information
11.9.2 IDx, LLC AI-based Diabetic Eye Disease Screening System Product Offered
11.9.3 IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 IDx, LLC Main Business Overview
11.9.5 IDx, LLC Latest Developments
11.10 Zhenhealth
11.10.1 Zhenhealth Company Information
11.10.2 Zhenhealth AI-based Diabetic Eye Disease Screening System Product Offered
11.10.3 Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Zhenhealth Main Business Overview
11.10.5 Zhenhealth Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
2.1.2 AI-based Diabetic Eye Disease Screening System Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for AI-based Diabetic Eye Disease Screening System by Country/Region (2021, 2025 & 2032)
2.2 AI-based Diabetic Eye Disease Screening System Segment by Type
2.2.1 On-premise
2.2.2 Cloud-based
2.2.3 Hybrid Mode
2.2.4 AI-based Diabetic Eye Disease Screening System Market Size by Type
2.2.4.1 AI-based Diabetic Eye Disease Screening System Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
2.3 AI-based Diabetic Eye Disease Screening System Segment by Business Model
2.3.1 Software Licensing
2.3.2 SaaS Subscription
2.3.3 Per-Screening Fee
2.3.4 Integrated AI + Hardware Sales
2.3.5 Others
2.3.6 AI-based Diabetic Eye Disease Screening System Market Size by Business Model
2.3.6.1 AI-based Diabetic Eye Disease Screening System Market Size CAGR by Business Model (2021 VS 2025 VS 2032)
2.3.6.2 Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model (2021-2026)
2.4 AI-based Diabetic Eye Disease Screening System Segment by Application
2.4.1 General Hospitals
2.4.2 Ophthalmology Hospitals
2.4.3 Diabetes Specialty Hospitals
2.4.4 AI-based Diabetic Eye Disease Screening System Market Size by Application
2.4.4.1 AI-based Diabetic Eye Disease Screening System Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.4.4.2 Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
3 AI-BASED DIABETIC EYE DISEASE SCREENING SYSTEM MARKET SIZE BY PLAYER
3.1 AI-based Diabetic Eye Disease Screening System Market Size Market Share by Player
3.1.1 Global AI-based Diabetic Eye Disease Screening System Revenue by Player (2021-2026)
3.1.2 Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Player (2021-2026)
3.2 Global AI-based Diabetic Eye Disease Screening System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-BASED DIABETIC EYE DISEASE SCREENING SYSTEM BY REGION
4.1 AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026)
4.2 Global AI-based Diabetic Eye Disease Screening System Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI-based Diabetic Eye Disease Screening System Market Size Growth (2021-2026)
4.4 APAC AI-based Diabetic Eye Disease Screening System Market Size Growth (2021-2026)
4.5 Europe AI-based Diabetic Eye Disease Screening System Market Size Growth (2021-2026)
4.6 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
5.2 Americas AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
5.3 Americas AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026)
6.2 APAC AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
6.3 APAC AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
7.2 Europe AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
7.3 Europe AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI-based Diabetic Eye Disease Screening System by Region (2021-2026)
8.2 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
8.3 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI-BASED DIABETIC EYE DISEASE SCREENING SYSTEM MARKET FORECAST
10.1 Global AI-based Diabetic Eye Disease Screening System Forecast by Region (2027-2032)
10.1.1 Global AI-based Diabetic Eye Disease Screening System Forecast by Region (2027-2032)
10.1.2 Americas AI-based Diabetic Eye Disease Screening System Forecast
10.1.3 APAC AI-based Diabetic Eye Disease Screening System Forecast
10.1.4 Europe AI-based Diabetic Eye Disease Screening System Forecast
10.1.5 Middle East & Africa AI-based Diabetic Eye Disease Screening System Forecast
10.2 Americas AI-based Diabetic Eye Disease Screening System Forecast by Country (2027-2032)
10.2.1 United States Market AI-based Diabetic Eye Disease Screening System Forecast
10.2.2 Canada Market AI-based Diabetic Eye Disease Screening System Forecast
10.2.3 Mexico Market AI-based Diabetic Eye Disease Screening System Forecast
10.2.4 Brazil Market AI-based Diabetic Eye Disease Screening System Forecast
10.3 APAC AI-based Diabetic Eye Disease Screening System Forecast by Region (2027-2032)
10.3.1 China AI-based Diabetic Eye Disease Screening System Market Forecast
10.3.2 Japan Market AI-based Diabetic Eye Disease Screening System Forecast
10.3.3 Korea Market AI-based Diabetic Eye Disease Screening System Forecast
10.3.4 Southeast Asia Market AI-based Diabetic Eye Disease Screening System Forecast
10.3.5 India Market AI-based Diabetic Eye Disease Screening System Forecast
10.3.6 Australia Market AI-based Diabetic Eye Disease Screening System Forecast
10.4 Europe AI-based Diabetic Eye Disease Screening System Forecast by Country (2027-2032)
10.4.1 Germany Market AI-based Diabetic Eye Disease Screening System Forecast
10.4.2 France Market AI-based Diabetic Eye Disease Screening System Forecast
10.4.3 UK Market AI-based Diabetic Eye Disease Screening System Forecast
10.4.4 Italy Market AI-based Diabetic Eye Disease Screening System Forecast
10.4.5 Russia Market AI-based Diabetic Eye Disease Screening System Forecast
10.5 Middle East & Africa AI-based Diabetic Eye Disease Screening System Forecast by Region (2027-2032)
10.5.1 Egypt Market AI-based Diabetic Eye Disease Screening System Forecast
10.5.2 South Africa Market AI-based Diabetic Eye Disease Screening System Forecast
10.5.3 Israel Market AI-based Diabetic Eye Disease Screening System Forecast
10.5.4 Turkey Market AI-based Diabetic Eye Disease Screening System Forecast
10.6 Global AI-based Diabetic Eye Disease Screening System Forecast by Type (2027-2032)
10.7 Global AI-based Diabetic Eye Disease Screening System Forecast by Application (2027-2032)
10.7.1 GCC Countries Market AI-based Diabetic Eye Disease Screening System Forecast
11 KEY PLAYERS ANALYSIS
11.1 Eyenuk
11.1.1 Eyenuk Company Information
11.1.2 Eyenuk AI-based Diabetic Eye Disease Screening System Product Offered
11.1.3 Eyenuk AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Eyenuk Main Business Overview
11.1.5 Eyenuk Latest Developments
11.2 AEYE Health
11.2.1 AEYE Health Company Information
11.2.2 AEYE Health AI-based Diabetic Eye Disease Screening System Product Offered
11.2.3 AEYE Health AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 AEYE Health Main Business Overview
11.2.5 AEYE Health Latest Developments
11.3 Optomed
11.3.1 Optomed Company Information
11.3.2 Optomed AI-based Diabetic Eye Disease Screening System Product Offered
11.3.3 Optomed AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Optomed Main Business Overview
11.3.5 Optomed Latest Developments
11.4 Remidio
11.4.1 Remidio Company Information
11.4.2 Remidio AI-based Diabetic Eye Disease Screening System Product Offered
11.4.3 Remidio AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Remidio Main Business Overview
11.4.5 Remidio Latest Developments
11.5 Retmarker
11.5.1 Retmarker Company Information
11.5.2 Retmarker AI-based Diabetic Eye Disease Screening System Product Offered
11.5.3 Retmarker AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Retmarker Main Business Overview
11.5.5 Retmarker Latest Developments
11.6 VoxelCloud
11.6.1 VoxelCloud Company Information
11.6.2 VoxelCloud AI-based Diabetic Eye Disease Screening System Product Offered
11.6.3 VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 VoxelCloud Main Business Overview
11.6.5 VoxelCloud Latest Developments
11.7 Airdoc
11.7.1 Airdoc Company Information
11.7.2 Airdoc AI-based Diabetic Eye Disease Screening System Product Offered
11.7.3 Airdoc AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Airdoc Main Business Overview
11.7.5 Airdoc Latest Developments
11.8 Zhiyuan Huitu
11.8.1 Zhiyuan Huitu Company Information
11.8.2 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product Offered
11.8.3 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Zhiyuan Huitu Main Business Overview
11.8.5 Zhiyuan Huitu Latest Developments
11.9 IDx, LLC
11.9.1 IDx, LLC Company Information
11.9.2 IDx, LLC AI-based Diabetic Eye Disease Screening System Product Offered
11.9.3 IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 IDx, LLC Main Business Overview
11.9.5 IDx, LLC Latest Developments
11.10 Zhenhealth
11.10.1 Zhenhealth Company Information
11.10.2 Zhenhealth AI-based Diabetic Eye Disease Screening System Product Offered
11.10.3 Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Zhenhealth Main Business Overview
11.10.5 Zhenhealth Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. AI-based Diabetic Eye Disease Screening System Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. AI-based Diabetic Eye Disease Screening System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of On-premise
Table 4. Major Players of Cloud-based
Table 5. Major Players of Hybrid Mode
Table 6. AI-based Diabetic Eye Disease Screening System Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026) & ($ millions)
Table 8. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Software Licensing
Table 10. Major Players of SaaS Subscription
Table 11. Major Players of Per-Screening Fee
Table 12. Major Players of Integrated AI + Hardware Sales
Table 13. Major Players of Others
Table 14. AI-based Diabetic Eye Disease Screening System Market Size CAGR by Business Model (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global AI-based Diabetic Eye Disease Screening System Market Size by Business Model (2021-2026) & ($ millions)
Table 16. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model (2021-2026)
Table 17. AI-based Diabetic Eye Disease Screening System Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & ($ millions)
Table 19. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
Table 20. Global AI-based Diabetic Eye Disease Screening System Revenue by Player (2021-2026) & ($ millions)
Table 21. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Player (2021-2026)
Table 22. AI-based Diabetic Eye Disease Screening System Key Players Head office and Products Offered
Table 23. AI-based Diabetic Eye Disease Screening System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026) & ($ millions)
Table 27. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Region (2021-2026)
Table 28. Global AI-based Diabetic Eye Disease Screening System Revenue by Country/Region (2021-2026) & ($ millions)
Table 29. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Country/Region (2021-2026)
Table 30. Americas AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026) & ($ millions)
Table 31. Americas AI-based Diabetic Eye Disease Screening System Market Size Market Share by Country (2021-2026)
Table 32. Americas AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026) & ($ millions)
Table 33. Americas AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
Table 34. Americas AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & ($ millions)
Table 35. Americas AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
Table 36. APAC AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026) & ($ millions)
Table 37. APAC AI-based Diabetic Eye Disease Screening System Market Size Market Share by Region (2021-2026)
Table 38. APAC AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026) & ($ millions)
Table 39. APAC AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & ($ millions)
Table 40. Europe AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026) & ($ millions)
Table 41. Europe AI-based Diabetic Eye Disease Screening System Market Size Market Share by Country (2021-2026)
Table 42. Europe AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026) & ($ millions)
Table 43. Europe AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & ($ millions)
Table 44. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026) & ($ millions)
Table 45. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026) & ($ millions)
Table 46. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & ($ millions)
Table 47. Key Market Drivers & Growth Opportunities of AI-based Diabetic Eye Disease Screening System
Table 48. Key Market Challenges & Risks of AI-based Diabetic Eye Disease Screening System
Table 49. Key Industry Trends of AI-based Diabetic Eye Disease Screening System
Table 50. Global AI-based Diabetic Eye Disease Screening System Market Size Forecast by Region (2027-2032) & ($ millions)
Table 51. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share Forecast by Region (2027-2032)
Table 52. Global AI-based Diabetic Eye Disease Screening System Market Size Forecast by Type (2027-2032) & ($ millions)
Table 53. Global AI-based Diabetic Eye Disease Screening System Market Size Forecast by Application (2027-2032) & ($ millions)
Table 54. Eyenuk Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 55. Eyenuk AI-based Diabetic Eye Disease Screening System Product Offered
Table 56. Eyenuk AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 57. Eyenuk Main Business
Table 58. Eyenuk Latest Developments
Table 59. AEYE Health Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 60. AEYE Health AI-based Diabetic Eye Disease Screening System Product Offered
Table 61. AEYE Health AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. AEYE Health Main Business
Table 63. AEYE Health Latest Developments
Table 64. Optomed Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 65. Optomed AI-based Diabetic Eye Disease Screening System Product Offered
Table 66. Optomed AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Optomed Main Business
Table 68. Optomed Latest Developments
Table 69. Remidio Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 70. Remidio AI-based Diabetic Eye Disease Screening System Product Offered
Table 71. Remidio AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Remidio Main Business
Table 73. Remidio Latest Developments
Table 74. Retmarker Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 75. Retmarker AI-based Diabetic Eye Disease Screening System Product Offered
Table 76. Retmarker AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Retmarker Main Business
Table 78. Retmarker Latest Developments
Table 79. VoxelCloud Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 80. VoxelCloud AI-based Diabetic Eye Disease Screening System Product Offered
Table 81. VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. VoxelCloud Main Business
Table 83. VoxelCloud Latest Developments
Table 84. Airdoc Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 85. Airdoc AI-based Diabetic Eye Disease Screening System Product Offered
Table 86. Airdoc AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Airdoc Main Business
Table 88. Airdoc Latest Developments
Table 89. Zhiyuan Huitu Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 90. Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product Offered
Table 91. Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Zhiyuan Huitu Main Business
Table 93. Zhiyuan Huitu Latest Developments
Table 94. IDx, LLC Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 95. IDx, LLC AI-based Diabetic Eye Disease Screening System Product Offered
Table 96. IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. IDx, LLC Main Business
Table 98. IDx, LLC Latest Developments
Table 99. Zhenhealth Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 100. Zhenhealth AI-based Diabetic Eye Disease Screening System Product Offered
Table 101. Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Zhenhealth Main Business
Table 103. Zhenhealth Latest Developments
Table 1. AI-based Diabetic Eye Disease Screening System Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. AI-based Diabetic Eye Disease Screening System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of On-premise
Table 4. Major Players of Cloud-based
Table 5. Major Players of Hybrid Mode
Table 6. AI-based Diabetic Eye Disease Screening System Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026) & ($ millions)
Table 8. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Software Licensing
Table 10. Major Players of SaaS Subscription
Table 11. Major Players of Per-Screening Fee
Table 12. Major Players of Integrated AI + Hardware Sales
Table 13. Major Players of Others
Table 14. AI-based Diabetic Eye Disease Screening System Market Size CAGR by Business Model (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global AI-based Diabetic Eye Disease Screening System Market Size by Business Model (2021-2026) & ($ millions)
Table 16. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model (2021-2026)
Table 17. AI-based Diabetic Eye Disease Screening System Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & ($ millions)
Table 19. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
Table 20. Global AI-based Diabetic Eye Disease Screening System Revenue by Player (2021-2026) & ($ millions)
Table 21. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Player (2021-2026)
Table 22. AI-based Diabetic Eye Disease Screening System Key Players Head office and Products Offered
Table 23. AI-based Diabetic Eye Disease Screening System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026) & ($ millions)
Table 27. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Region (2021-2026)
Table 28. Global AI-based Diabetic Eye Disease Screening System Revenue by Country/Region (2021-2026) & ($ millions)
Table 29. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Country/Region (2021-2026)
Table 30. Americas AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026) & ($ millions)
Table 31. Americas AI-based Diabetic Eye Disease Screening System Market Size Market Share by Country (2021-2026)
Table 32. Americas AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026) & ($ millions)
Table 33. Americas AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
Table 34. Americas AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & ($ millions)
Table 35. Americas AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
Table 36. APAC AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026) & ($ millions)
Table 37. APAC AI-based Diabetic Eye Disease Screening System Market Size Market Share by Region (2021-2026)
Table 38. APAC AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026) & ($ millions)
Table 39. APAC AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & ($ millions)
Table 40. Europe AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026) & ($ millions)
Table 41. Europe AI-based Diabetic Eye Disease Screening System Market Size Market Share by Country (2021-2026)
Table 42. Europe AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026) & ($ millions)
Table 43. Europe AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & ($ millions)
Table 44. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026) & ($ millions)
Table 45. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026) & ($ millions)
Table 46. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & ($ millions)
Table 47. Key Market Drivers & Growth Opportunities of AI-based Diabetic Eye Disease Screening System
Table 48. Key Market Challenges & Risks of AI-based Diabetic Eye Disease Screening System
Table 49. Key Industry Trends of AI-based Diabetic Eye Disease Screening System
Table 50. Global AI-based Diabetic Eye Disease Screening System Market Size Forecast by Region (2027-2032) & ($ millions)
Table 51. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share Forecast by Region (2027-2032)
Table 52. Global AI-based Diabetic Eye Disease Screening System Market Size Forecast by Type (2027-2032) & ($ millions)
Table 53. Global AI-based Diabetic Eye Disease Screening System Market Size Forecast by Application (2027-2032) & ($ millions)
Table 54. Eyenuk Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 55. Eyenuk AI-based Diabetic Eye Disease Screening System Product Offered
Table 56. Eyenuk AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 57. Eyenuk Main Business
Table 58. Eyenuk Latest Developments
Table 59. AEYE Health Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 60. AEYE Health AI-based Diabetic Eye Disease Screening System Product Offered
Table 61. AEYE Health AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. AEYE Health Main Business
Table 63. AEYE Health Latest Developments
Table 64. Optomed Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 65. Optomed AI-based Diabetic Eye Disease Screening System Product Offered
Table 66. Optomed AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Optomed Main Business
Table 68. Optomed Latest Developments
Table 69. Remidio Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 70. Remidio AI-based Diabetic Eye Disease Screening System Product Offered
Table 71. Remidio AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Remidio Main Business
Table 73. Remidio Latest Developments
Table 74. Retmarker Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 75. Retmarker AI-based Diabetic Eye Disease Screening System Product Offered
Table 76. Retmarker AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Retmarker Main Business
Table 78. Retmarker Latest Developments
Table 79. VoxelCloud Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 80. VoxelCloud AI-based Diabetic Eye Disease Screening System Product Offered
Table 81. VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. VoxelCloud Main Business
Table 83. VoxelCloud Latest Developments
Table 84. Airdoc Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 85. Airdoc AI-based Diabetic Eye Disease Screening System Product Offered
Table 86. Airdoc AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Airdoc Main Business
Table 88. Airdoc Latest Developments
Table 89. Zhiyuan Huitu Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 90. Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product Offered
Table 91. Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Zhiyuan Huitu Main Business
Table 93. Zhiyuan Huitu Latest Developments
Table 94. IDx, LLC Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 95. IDx, LLC AI-based Diabetic Eye Disease Screening System Product Offered
Table 96. IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. IDx, LLC Main Business
Table 98. IDx, LLC Latest Developments
Table 99. Zhenhealth Details, Company Type, AI-based Diabetic Eye Disease Screening System Area Served and Its Competitors
Table 100. Zhenhealth AI-based Diabetic Eye Disease Screening System Product Offered
Table 101. Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Zhenhealth Main Business
Table 103. Zhenhealth Latest Developments
LIST OF FIGURES
Figure 1. AI-based Diabetic Eye Disease Screening System Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. AI-based Diabetic Eye Disease Screening System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. AI-based Diabetic Eye Disease Screening System Sales Market Share by Country/Region (2025)
Figure 8. AI-based Diabetic Eye Disease Screening System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type in 2025
Figure 10. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model in 2025
Figure 11. AI-based Diabetic Eye Disease Screening System in General Hospitals
Figure 12. Global AI-based Diabetic Eye Disease Screening System Market: General Hospitals (2021-2026) & ($ millions)
Figure 13. AI-based Diabetic Eye Disease Screening System in Ophthalmology Hospitals
Figure 14. Global AI-based Diabetic Eye Disease Screening System Market: Ophthalmology Hospitals (2021-2026) & ($ millions)
Figure 15. AI-based Diabetic Eye Disease Screening System in Diabetes Specialty Hospitals
Figure 16. Global AI-based Diabetic Eye Disease Screening System Market: Diabetes Specialty Hospitals (2021-2026) & ($ millions)
Figure 17. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application in 2025
Figure 18. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Player in 2025
Figure 19. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Region (2021-2026)
Figure 20. Americas AI-based Diabetic Eye Disease Screening System Market Size 2021-2026 ($ millions)
Figure 21. APAC AI-based Diabetic Eye Disease Screening System Market Size 2021-2026 ($ millions)
Figure 22. Europe AI-based Diabetic Eye Disease Screening System Market Size 2021-2026 ($ millions)
Figure 23. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size 2021-2026 ($ millions)
Figure 24. Americas AI-based Diabetic Eye Disease Screening System Value Market Share by Country in 2025
Figure 25. United States AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 26. Canada AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 27. Mexico AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 28. Brazil AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 29. APAC AI-based Diabetic Eye Disease Screening System Market Size Market Share by Region in 2025
Figure 30. APAC AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
Figure 31. APAC AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
Figure 32. China AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 33. Japan AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 34. South Korea AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 35. Southeast Asia AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 36. India AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 37. Australia AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 38. Europe AI-based Diabetic Eye Disease Screening System Market Size Market Share by Country in 2025
Figure 39. Europe AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
Figure 40. Europe AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
Figure 41. Germany AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 42. France AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 43. UK AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 44. Italy AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 45. Russia AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 46. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size Market Share by Region (2021-2026)
Figure 47. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
Figure 48. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
Figure 49. Egypt AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 50. South Africa AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 51. Israel AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 52. Turkey AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 53. GCC Countries AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 54. Americas AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 55. APAC AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 56. Europe AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 57. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 58. United States AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 59. Canada AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 60. Mexico AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 61. Brazil AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 62. China AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 63. Japan AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 64. Korea AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 65. Southeast Asia AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 66. India AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 67. Australia AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 68. Germany AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 69. France AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 70. UK AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 71. Italy AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 72. Russia AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 73. Egypt AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 74. South Africa AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 75. Israel AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 76. Turkey AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 77. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share Forecast by Type (2027-2032)
Figure 78. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share Forecast by Application (2027-2032)
Figure 79. GCC Countries AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 1. AI-based Diabetic Eye Disease Screening System Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. AI-based Diabetic Eye Disease Screening System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. AI-based Diabetic Eye Disease Screening System Sales Market Share by Country/Region (2025)
Figure 8. AI-based Diabetic Eye Disease Screening System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type in 2025
Figure 10. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model in 2025
Figure 11. AI-based Diabetic Eye Disease Screening System in General Hospitals
Figure 12. Global AI-based Diabetic Eye Disease Screening System Market: General Hospitals (2021-2026) & ($ millions)
Figure 13. AI-based Diabetic Eye Disease Screening System in Ophthalmology Hospitals
Figure 14. Global AI-based Diabetic Eye Disease Screening System Market: Ophthalmology Hospitals (2021-2026) & ($ millions)
Figure 15. AI-based Diabetic Eye Disease Screening System in Diabetes Specialty Hospitals
Figure 16. Global AI-based Diabetic Eye Disease Screening System Market: Diabetes Specialty Hospitals (2021-2026) & ($ millions)
Figure 17. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application in 2025
Figure 18. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Player in 2025
Figure 19. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share by Region (2021-2026)
Figure 20. Americas AI-based Diabetic Eye Disease Screening System Market Size 2021-2026 ($ millions)
Figure 21. APAC AI-based Diabetic Eye Disease Screening System Market Size 2021-2026 ($ millions)
Figure 22. Europe AI-based Diabetic Eye Disease Screening System Market Size 2021-2026 ($ millions)
Figure 23. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size 2021-2026 ($ millions)
Figure 24. Americas AI-based Diabetic Eye Disease Screening System Value Market Share by Country in 2025
Figure 25. United States AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 26. Canada AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 27. Mexico AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 28. Brazil AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 29. APAC AI-based Diabetic Eye Disease Screening System Market Size Market Share by Region in 2025
Figure 30. APAC AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
Figure 31. APAC AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
Figure 32. China AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 33. Japan AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 34. South Korea AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 35. Southeast Asia AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 36. India AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 37. Australia AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 38. Europe AI-based Diabetic Eye Disease Screening System Market Size Market Share by Country in 2025
Figure 39. Europe AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
Figure 40. Europe AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
Figure 41. Germany AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 42. France AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 43. UK AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 44. Italy AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 45. Russia AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 46. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size Market Share by Region (2021-2026)
Figure 47. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2026)
Figure 48. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2026)
Figure 49. Egypt AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 50. South Africa AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 51. Israel AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 52. Turkey AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 53. GCC Countries AI-based Diabetic Eye Disease Screening System Market Size Growth 2021-2026 ($ millions)
Figure 54. Americas AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 55. APAC AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 56. Europe AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 57. Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 58. United States AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 59. Canada AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 60. Mexico AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 61. Brazil AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 62. China AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 63. Japan AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 64. Korea AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 65. Southeast Asia AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 66. India AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 67. Australia AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 68. Germany AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 69. France AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 70. UK AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 71. Italy AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 72. Russia AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 73. Egypt AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 74. South Africa AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 75. Israel AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 76. Turkey AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
Figure 77. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share Forecast by Type (2027-2032)
Figure 78. Global AI-based Diabetic Eye Disease Screening System Market Size Market Share Forecast by Application (2027-2032)
Figure 79. GCC Countries AI-based Diabetic Eye Disease Screening System Market Size 2027-2032 ($ millions)
